'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease

Cardiovascular Diabetology

Volumn 6, Issue , 2007, Pages

  Schaan, Beatriz D ^a,d   Quadros, Alexandre S ^a   Sarmento Leite, Rogério ^a   De Lucca Jr , Giuseppe ^a   Bender, Alexandra ^a   Bertoluci, Marcello ^b,c  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; C REACTIVE PROTEIN; GLUCOSE; INSULIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGE; AGED; ANALYSIS OF VARIANCE; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; PATIENT CODING; POST HOC ANALYSIS; PROTEIN BLOOD LEVEL; STROKE; SYSTOLIC BLOOD PRESSURE; UNIVARIATE ANALYSIS; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; DIABETIC ANGIOPATHY; FOLLOW UP; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; RADIOGRAPHY; SINGLE BLIND PROCEDURE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SINGLE-BLIND METHOD; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34548779773     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-6-19     Document Type: Article

References (29)

1. Libby P Inflammation in atherosclerosis. Nature 2002, 420(6917):868-874. 10.1038/nature01323 12490960
2. Stamler J Vaccaro O Neaton JD Wentworth D Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care UNITED STATES 1993, 16 (2):434-444. 10.2337/diacare.16.2.434 8432214
3. Maemura K Kurihara H Morita T Oh-hashi Y Yazaki Y Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury. Gerontology 1992, 38 (Suppl 1):29-35. 1459470
4. Sarzani R Brecher P Chobanian AV Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest 1989, 83(4):1404-1408. 303835 2703537
5. Zuckerman SH Panousis C Evans G TGF-beta reduced binding of high-density lipoproteins in murine macrophages and macrophage-derived foam cells. Atherosclerosis 2001, 155(1)79-85. 10.1016/S0021-9150(00)00540-2 11223429
6. Robertson AK Rudling M Zhou X Gorelik L Flavell RA Hansson GK Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest 2003, 112(9):1342-1350. 228445 14568988 10.1172/JCI200318607
7. Mallat Z Gojova A Marchiol-Fournigault C Esposito B Kamate C Merval R Fradelizi D Tedgui A Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 2001, 89 (10):930-934. 11701621
8. Fukumoto H Naito Z Asano G Aramaki T Immunohistochemical and morphometric evaluations of coronary atherosclerotic plaques associated with myocardial infarction and diabetes mellitus. J Atheroscler Thromb 1998, 5(1):29-35. 10077455
9. Nikol S Isner JM Pickering JG Kearney M Leclerc G Weir L Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest 1992, 90(4)1582-1592. 443206 1328302
10. Crook R Leatham, EW, Salomone, OA, Hossein-Nia, M, Grainger, DJ, Kaski, JC. Plasma levels of active transforming growth factor-beta are reduced in patients with three vessel coronary artery disease. Heart 1996 75(5S):79p
11. Grainger DJ Kemp PR Metcalfe JC Liu AC Lawn RM Williams NR Grace AA Schofield PM Chauhan A The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med 1995, 1(1):74-79. 10.1038/nm0195-74 7584958
12. Tashiro H Shimokawa H Yamamoto K Momohara M Tada H Takeshita A Altered plasma levels of cytokines in patients with ischemic heart disease. Coron Artery Dis 1997, 8(3-4):143-147. 9237023
13. Batuman O Go D Clark LT Smith EL Clements P Feit A Lederer D Relationship between cytokine levels and coronary artery disease in women. Heart Dis 2001, 3(2):80-84. 10.1097/00132580-200103000-00004 11975775
14. Tashiro H Shimokawa H Sadamatu K Yamamoto K Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease. Coron Artery Dis 2002, 13(3):139-143. 10.1097/00019501-200205000-00001 12131016
15. Wang XL Liu SX Wilcken DE Circulating transforming growth factor beta 1 and coronary artery disease. Cardiovasc Res 1997, 34 (2):404-410. 10.1016/S0008-6363(97)00033-3 9205555
16. Smith SC Jr. Dove JT Jacobs AK Kennedy JW Kereiakes D Kern MJ Kuntz RE Popma JJ Schaff HV Williams DO Gibbons RJ Alpert JP Eagle KA Faxon DP Fuster V Gardner TJ Gregoratos G Russell RO ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation 2001, 103(24):3019-3041. 11413094
17. Matthews DR Hosker JP Rudenski AS Naylor BA Treacher DF Turner RC Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419. 10.1007/BF00280883 3899825
18. Merwin JR Anderson JM Kocher O Van Itallie CM Madri JA Transforming growth factor beta 1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J Cell Physiol 1990, 142(1):117-128. 10.1002/jcp.1041420115 1688859
19. Morisaki N Kawano M Koyama N Koshikawa T Umemiya K Saito Y Yoshida S Effects of transforming growth factor-beta 1 on growth of aortic smooth muscle cells. Influences of interaction with growth factors, cell state, cell phenotype, and cell cycle. Atherosclerosis 1991, 88(2-3):227-234. 10.1016/0021-9150(91)90085-H 1892488
20. Li CG Bethell H Wilson PB Bhatnagar D Walker MG Kumar S The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery disease. Atherosclerosis 2000, 152(1):249-256. 10.1016/ S0021-9150(99)00476-1 10996361
21. Border WA Ruoslahti E Transforming growth factor-beta in disease: The dark side of tissue repair. J Clin Invest 1992, 90(1):1-7. 443055 1634602
22. Ohji T Urano H Shirahata A Yamagishi M Higashi K Gotoh S Karasaki Y Transforming growth factor beta 1 and beta 2 induce down-modulation of thrombomodulin in human umbilical vein endothelial cells. Thromb Haemost 1995, 73(5):812-818. 7482408
23. Cagliero E Roth T Taylor AW Lorenzi M The effects of high glucose on human endothelial cell growth and gene expression are not mediated by transforming growth factor-beta. Lab Invest 1995, 73(5):667-673. 7474940
24. Ziyadeh FN Sharma K Ericksen M Wolf G Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 1994, 93(2):536-542. 293875 8113392
25. Stefoni S Cianciolo G Donati G Dormi A Silvestri MG Coli L De Pascalis A Iannelli S Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Int 2002, 61(1):324-335. 10.1046/j.1523-1755.2002.00119.x 11786115
26. Os I Djurovic S Seljeflot I Berg K Transforming growth factor (TGF)-beta1 inversely related to vascular cell adhesion molecule-1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative cardioprotective role of TGF-beta1? J Intern Med 2002, 251(3):223-227. 10.1046/j.1365-2796.2002.00950.x 11886481
27. Erren M Reinecke H Junker R Fobker M Schulte H Schurek JO Kropf J Kerber S Breithardt G Assmann G Cullen P Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999, 19(10):2355-2363. 10521364
28. Bertoluci MC Uebel D Schmidt A Thomazelli FC Oliveira FR Schmid H Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy. Diabetes Res Clin Pract 2006, 72(3):258-264. 10.1016/ j.diabres.2005.10.027 16414143
29. Okamoto Y Gotoh Y Uemura O Tanaka S Ando T Nishida M Age-dependent decrease in serum transforming growth factor (TGF)-beta 1 in healthy Japanese individuals; population study of serum TGF-beta 1 level in Japanese. Dis Markers 2005, 21(2):71-74. 15920293